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The novel coronavirus, SARS-CoV-2, has spread across the world 
within months of its first description in Wuhan, China in December 
2019, resulting in an unprecedented global health emergency. Whilst 
Europe and North America are the current epicentres of infection, the 
global health community are preparing for the potential effects of this 
new disease on the African continent. Modelling studies predict that 
factors such as  youthful and rural population may be protective in 
mitigating the spread of COVID-19 in the World Health Organisation 
(WHO) African Region, however, with 220 million infections and 4.6 
million hospitalisations predicted in the first year of the pandemic 
alone, fragile health systems could still be placed under significant 
strain. Furthermore, subsequent disruptions to the provision of 
services for people living with HIV, or at risk of acquiring HIV, are 
predicted to lead to an extra 500,000 adult HIV deaths and a 2-fold 
increase in mother to child transmission of HIV in sub-Saharan Africa 
in 2020-2021. Ignoring these predictions may have severe 
consequences and we risk “stepping back in time” in AIDS-related 
deaths to numbers seen over a decade ago. Reflecting on our current 
experience of the COVID-19 pandemic in Uganda, we explore the 
potential impact of public health measures implemented to mitigate 
spread of COVID-19 on the HIV care continuum, and suggest areas of 
focus for HIV services, policy makers and governments to urgently 
address in order to minimise the collateral damage.
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Introduction
Coronavirus disease 2019 (COVID-19), caused by the novel 
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), 
was first described in Wuhan, China in December 2019 and 
to date there have been more than 106,375,662 confirmed 
cases, with at least 2,321,294 deaths, globally1. Recent model-
ling studies predict fewer deaths and severe infections in Africa 
compared to the United States and Europe, potentially due 
to a younger and more rural population. Despite this, it is 
predicted that within the first year nearly a quarter of Africa’s 
1 billion population may be infected with the pandemic 
continuing for a longer period with 4.6 million hospitalisations, 
which will still pose a significant strain on health systems2,3. 
Sobering estimates from World Health Organisation (WHO) and 
UNAIDS suggest a disruption in antiretroviral therapy (ART) 
due to COVID-19 could lead to more than 500,000 extra deaths 
from AIDS-related opportunistic infections in sub-Saharan 
Africa and reverse gains made in preventing mother-to-child 
transmission of HIV, with an increase in new child infec-
tions of up to 104% in Uganda4. These figures were described 
by Dr Tedros Adhanom Ghebreyesus, Director-General of 
the WHO as “stepping back into history”5. In this commen-
tary, we present Uganda as an example of a sub-Saharan 
African country who quickly enacted strict containment meas-
ures. Though the article makes reference to the fact that 
Uganda may have successfully curbed the spread of 
COVID-19, there is limited evidence such as delayed commu-
nity transmission, limited number of cases, reducing new infec-
tions  to support the statement. The success of these containment 
measures may result in profound consequences on the HIV care 
continuum. We suggest globally applicable measures for HIV 
service providers, government and policy makers to urgently 
consider in order to minimise the lasting collateral damage 
to HIV prevention and treatment efforts threatened by this 
pandemic.
COVID-19 challenges and the HIV Care Continuum in 
Uganda
Uganda has a population of almost 43 million people including 
1.4 million people living with HIV (PLHIV)6,7. Excellent 
progress has been made towards the UNAIDS “90-90-90” 2020 
targets with 84% of the population aware of their HIV status 
and 87% of these on ART, of which 88% of people are virally 
suppressed. At its peak in the 1990’s, Uganda’s HIV prevalence 
was 18–30%, which was reduced to 5.7% in 2019, largely due 
to the roll out of antiretroviral therapy (ART) and extensive 
public health campaigns around the importance of HIV testing, 
initiating ART and counselling on drug adherence7.
The current pandemic and instituted control measures threat-
ens to reverse these accomplishments. As soon as the first case 
of COVID-19 was identified in Uganda on 19th March 2020, 
strict lockdown measures were enforced, including a ban on all 
public and private transport, night curfew, closure of schools, 
suspension of religious and social gatherings, and closure of 
non-essential shops and markets8. Firstly, these measures present 
barriers to HIV testing, in particular initiatives for testing 
Uganda’s most vulnerable groups, including workplace test-
ing, mobile mass testing campaigns and self-testing amongst 
fishermen, sex-workers and male partners of women attending 
antenatal care7. For those with a new diagnosis of HIV, closures 
of clinics and the practicalities of leaving the house during 
lockdown prohibit essential linkage to care. However, our grav-
est concern is the real possibility of substantial ART interruption. 
Global lockdowns and travel restrictions threaten manufacture 
and supply, particularly to tenofovir-lamivudine-efavirenz and 
tenofovir-lamivudine-dolutegravir, which is first line therapy 
for an estimated 80% of PLHIV in low- and middle-income 
countries9. Lopinivir and ritonavir global supply was also particu-
larly threatened, given initial interest in its use as an experimen-
tal therapeutic agent for COVID-1910. In Uganda, this is likely 
multifactorial: supply chain issues as borders are closed, the 
inability of people to leave their homes to obtain essential medi-
cations, and people relocating to villages away from their HIV 
clinics. Additionally, there is the dire situation of poverty and 
hunger faced by many individuals, where mere survival rather 
than maintaining HIV care has become the priority. This dis-
ruption in ART access has very real consequences on those 
who were previously adherent to ART and virologically 
suppressed. Significant lapses in HIV virological suppres-
sion may result in increased community transmission of HIV in 
Uganda and other comparable settings, which would represent 
a catastrophic downstream effect of COVID-19 (Figure 1).
          Amendments from Version 1
Abstract: 
Article “a” has been removed from “a youthful and rural 
population”
Introduction:
Covid confirmed cases and deaths updated to current global 
figures.
Article “a” added to “younger and more rural population”, 
“Though the article makes reference to the fact that Uganda 
may have successfully curbed the spread of COVID-19, there 
is limited evidence such as delayed community transmission, 
limited number of cases, reducing new infections  to support the 
statement “ was added. 
Covid 19 challenges and HIV care continuum in Uganda:  
PLWHIV changed to PLHIV (People living with HIV) throughout 
the paper, “and instituted control measures” added to sentence 
in paragraph 2.
“Global lockdowns and travel restrictions threaten manufacture 
and supply, particularly to tenofovir-lamivudine-efavirenz and 
tenofovir-lamivudine-dolutegravir, which is first line therapy for 
an estimated 80% of PLHIV in low- and middle-income countries. 
Lopinivir and ritonavir global supply was also particularly 
threatened, given initial interest in its use as an experimental 
therapeutic agent for COVID-19”  added to bring out interruption 
in ART supply chain
Respective references added.
Improved epidemic preparedness:
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Figure  1.  Challenges  posed  to  the  HIV  care  continuum  by  the  COVID-19  pandemic.  COVID-19 -Coronavirus disease (2019), 
ART- Antiretroviral therapy.
Minimising collateral damage: focus points for HIV 
service providers, policy makers and Government
We suggest four focus points for HIV service providers, policy 
makers and governments to minimise collateral damage 
of the COVID-19 pandemic in Uganda, which are applicable 
to similar sub-Saharan African countries (Figure 2).
1. Increase in innovative, adaptive, decentralised, community-
based care. It is increasingly recognised that successful HIV 
care depends on adapting to the individual’s needs and expecta-
tions, especially in a pandemic11. One such measure already rec-
ommended by WHO in response to COVID-19 is multi-month 
ART prescriptions for stable patients12. However, ongoing 
maintenance of HIV care will require pro-active steps by HIV 
services, backed by adequate government funding and donor 
support. Adaptions to service delivery, such as telemedicine, 
must be incorporated so that clients can access essential care 
during prolonged lockdown. Hotlines should be set up in the 
event of an emergency, providing mobile credit allowance 
or toll-free numbers. Since less than 50% of the Ugandan popu-
lation own a mobile phone, there should be provision of simple 
handsets or access to a shared community phone. For those 
who have relocated back to rural communities, issuing a univer-
sal HIV passport allowing clients to access medication at any 
clinic would prevent unintentional ART interruption. Ensuring 
PLHIV have adequate food, water, soap and access to essential 
concomitant medications such as cotrimoxazole and fluconazole, 
are also essential and is something we have prioritised for the 
most vulnerable clients through donations at the Infectious 
Disease Institute, Kampala.
2. Increased community engagement. The community of 
PLHIV, particularly in Uganda, has a strong history of activ-
ism and peer support. For example, many HIV services have 
community advisory boards comprised of patient representa-
tives, religious and community leaders. In these challenging 
times, existing community networks, social media, radio and 
television should be leveraged to disseminate important 
public health messages pertaining to both COVID-19 preven-
tion and HIV care, including HIV testing, ART adherence and 
encouraging people to access healthcare when needed, even 
during lockdown periods.
3. Healthcare system strengthening. Uganda has strong vertical 
health programmes such as HIV, TB and malaria control 
programmes; however, pandemics quickly expose lack of 
horizontal integration and a fragile surrounding healthcare 
infrastructure13. COVID-19 will hopefully provide a wake-up 
call to government, donors and policy makers to invest in 
strengthening the Ugandan healthcare system so that essential 
HIV care can be maintained despite increased pressures posed 
by the pandemic. This should include increased training 
and retention of nursing, medical and auxiliary healthcare 
workers, ensuring adequate stock of medications and diagnostic 
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Figure  2.  Suggested  solutions  to  mitigate  some  of  the  major  impacts  of  COVID-19  to  HIV  care  and  health  systems  and 
management  of  future  pandemics.  COVID-19 -Coronavirus disease (2019), ART- Antiretroviral therapy, PPE - Personal Protective 
equipment.
laboratory equipment and provision of increased high-dependency 
unit beds and oxygen supply within government healthcare 
facilities, the only healthcare available to most Ugandans.
4. Improved epidemic preparedness. In the last 1 year, epi-
demic preparedness has become a top priority worldwide. In 
fact, at this time the global community might consider looking 
to Uganda’s experiences managing infectious epidemics 
such as HIV, Ebola, and Marburg for lessons in their own 
COVID-19 responses. Thankfully, COVID-19 spread in the 
African continent is predicted to be slower than in Europe and 
the United States, giving governments some time to prepare 
their responses2. Nevertheless, ongoing efforts are required to 
upscale testing and contact tracing, rapidly train and mobilise 
a COVID-19 workforce, source adequate personal protective 
equipment (PPE) and ensure adequate access to adequate 
clean water, soap, and sanitizers for both healthcare facili-
ties and the general population. In addition, emphasis should 
be placed on mobilisation of funds and streamlined regula-
tory processes to facilitate context-specific research on the 
epidemiology and clinical course of COVID-19 in PLHIV, to 
avoid reliance on research findings being extrapolated from 
the global North.
Conclusion
Failing to recognise the potential impact of the current pan-
demic on the HIV care continuum in Uganda, and similar 
sub-Saharan African countries, could result in a huge upsurge 
in HIV transmission and deaths in the months and years to 
come. In addition, increasing global travel, urbanization and 
changes in land use mean that future pandemics are almost 
inevitable14. Substantial action must be taken now by HIV 
service providers, policy makers and governments in sub-Saharan 
Africa to create innovative, sustainable and effective solu-
tions to prevent us “stepping back in time” in HIV care and 
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